🔬 Connecting with the Global Biotech Community
We are pleased to be attending BIOCHINA, where innovators from across the biotech ecosystem come together to discuss the future of drug development and global regulatory strategy. As more companies pursue international pathways for approval, thoughtful clinical planning and strong data strategies have never been more important. Our team looks forward to engaging with fellow leaders, sharing perspectives, and exploring how we can help advance complex therapies from development to regulatory success.
We are also looking forward to attending the CMAC Annual Meeting and spending time with colleagues across the clinical development ecosystem. It’s so valuable to step away from day-to-day program work and have thoughtful conversations about the evolving challenges in trial design, data strategy, and regulatory expectations. So we’re excited to exchange ideas, share perspectives from complex development programs, and connect with teams advancing the next generation of therapies.
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
Lorenzo Scalise: Business Development Representative
Daphne Smyth: Vice President Regulatory
AJ Mills: Executive Vice President
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.